CD44 and cancer: The activation of CD44 isoforms modulates the activities of the components of several signalling pathways including enzymes, protein kinase pathways, transcriptional factors and intracellular pathways to contribute to cancer cell proliferation, stemness, invasion, migration and metastasis, as well as drug resistance.